| 1 |
33416167 |
10.3892/or.2020.7888 |
2021 |
Involvement of Blnk and Foxo1 in tumor suppression in BCR‑ABL1‑transformed pro‑B cells. |
BLNK |
| 2 |
33570628 |
10.1182/bloodadvances.2020001665 |
2021 |
Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2. |
BLNK |
| 3 |
34653294 |
10.1111/cas.15164 |
2021 |
C/EBPβ induces B-cell acute lymphoblastic leukemia and cooperates with BLNK mutations. |
BLNK |
| 4 |
31882553 |
10.21873/cgp.20169 |
2020 |
BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach. |
BLNK |
| 5 |
32420699 |
10.1002/cam4.3136 |
2020 |
Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma. |
BLNK |
| 6 |
32585766 |
10.1002/1878-0261.12753 |
2020 |
Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphoma. |
BLNK |
| 7 |
33020271 |
10.1073/pnas.2007946117 |
2020 |
Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A. |
BLNK |
| 8 |
29931583 |
10.1007/s10637-018-0623-8 |
2019 |
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2. |
BLNK |
| 9 |
30872780 |
10.1038/s41375-019-0442-8 |
2019 |
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma. |
BLNK |
| 10 |
30890517 |
10.12122/j.issn.1673-4254.2019.02.20 |
2019 |
[Structure and function of B-cell linker and its role in the development of B cell-related diseases]. |
BLNK |
| 11 |
30402490 |
10.1155/2018/6728128 |
2018 |
Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion. |
BLNK |
| 12 |
26354285 |
10.1002/hon.2251 |
2017 |
Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma. |
BLNK |
| 13 |
28369050 |
10.1038/ni.3716 |
2017 |
Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. |
BLNK |
| 14 |
28791394 |
10.3892/mmr.2017.7158 |
2017 |
Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis. |
BLNK |
| 15 |
28972016 |
10.1182/blood-2017-06-743252 |
2017 |
Philadelphia chromosome-like acute lymphoblastic leukemia. |
BLNK |
| 16 |
26522721 |
10.1038/onc.2015.385 |
2016 |
ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway. |
BLNK |
| 17 |
26703467 |
10.1074/jbc.M115.637835 |
2016 |
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia. |
BLNK |
| 18 |
27016671 |
10.1016/j.molimm.2016.03.007 |
2016 |
PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling. |
BLNK |
| 19 |
28476192 |
10.1016/j.arcmed.2016.12.005 |
2016 |
Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse. |
BLNK |
| 20 |
25080849 |
10.1111/ejh.12427 |
2015 |
B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells. |
BLNK |
| 21 |
25391967 |
10.1007/s11060-014-1655-3 |
2015 |
Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system. |
BLNK |
| 22 |
24240734 |
10.1007/s00401-013-1202-x |
2014 |
Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice. |
BLNK |
| 23 |
24169826 |
10.1182/blood-2012-12-473090 |
2013 |
The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop. |
BLNK |
| 24 |
22262777 |
10.1182/blood-2011-04-351965 |
2012 |
CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells. |
BLNK |
| 25 |
22880054 |
10.1371/journal.pone.0042610 |
2012 |
Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas. |
BLNK |
| 26 |
22956576 |
10.4049/jimmunol.1201267 |
2012 |
Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia. |
BLNK |
| 27 |
23066158 |
10.4049/jimmunol.1201440 |
2012 |
Highly restricted usage of Ig H chain VH14 family gene segments in Slp65-deficient pre-B cell leukemia in mice. |
BLNK |
| 28 |
19758698 |
10.1016/j.leukres.2009.08.030 |
2010 |
Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma. |
BLNK |
| 29 |
20876806 |
10.1158/0008-5472.CAN-10-1438 |
2010 |
Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia. |
BLNK |
| 30 |
19047679 |
10.1182/blood-2008-07-166355 |
2009 |
BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. |
BLNK |
| 31 |
19150402 |
10.1016/j.cellsig.2008.12.006 |
2009 |
SAP binds to CD22 and regulates B cell inhibitory signaling and calcium flux. |
BLNK |
| 32 |
19850008 |
10.1016/j.bbrc.2009.10.070 |
2009 |
Phosphatidylinositol-3-kinase-dependent phosphorylation of SLP-76 by the lymphoma-associated ITK-SYK fusion-protein. |
BLNK |
| 33 |
19855081 |
10.1182/blood-2009-02-204362 |
2009 |
BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt. |
BLNK |
| 34 |
18006696 |
10.1182/blood-2007-07-100115 |
2008 |
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. |
BLNK |
| 35 |
18172310 |
10.1158/0008-5472.CAN-07-2778 |
2008 |
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells. |
BLNK |
| 36 |
18426802 |
10.1074/jbc.M708459200 |
2008 |
Induction of cytosolic calcium flux by CD20 is dependent upon B Cell antigen receptor signaling. |
BLNK |
| 37 |
18566961 |
10.1002/path.2384 |
2008 |
The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype. |
BLNK |
| 38 |
17717600 |
10.1172/JCI30842 |
2007 |
B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. |
BLNK |
| 39 |
16568084 |
10.1038/sj.onc.1209510 |
2006 |
The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells. |
BLNK |
| 40 |
16636677 |
10.1038/sj.onc.1209520 |
2006 |
SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells. |
BLNK |
| 41 |
16888096 |
10.1182/blood-2006-03-013821 |
2006 |
Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation. |
BLNK |
| 42 |
15744341 |
10.1038/sj.leu.2403702 |
2005 |
Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. |
BLNK |
| 43 |
12881301 |
10.1182/blood-2003-05-1487 |
2004 |
Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. |
BLNK |
| 44 |
14984504 |
10.1111/j.1365-2141.2004.04802.x |
2004 |
Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. |
BLNK |
| 45 |
15029213 |
10.1038/sj.leu.2403349 |
2004 |
Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia. |
BLNK |
| 46 |
15231650 |
10.1158/0008-5472.CAN-03-3885 |
2004 |
High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. |
BLNK |
| 47 |
12436112 |
10.1038/ni862 |
2003 |
The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. |
BLNK |
| 48 |
12761551 |
10.1038/nature01608 |
2003 |
Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. |
BLNK |
| 49 |
11489945 |
10.1084/jem.194.3.255 |
2001 |
Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. |
BLNK |
| 50 |
10498607 |
|
1999 |
Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. |
BLNK |
| 51 |
9341187 |
10.1074/jbc.272.43.27362 |
1997 |
Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cgamma, Grb2, and Vav after B cell antigen receptor activation. |
BLNK |
Datasets
Models
